Effect of Transfer Factor and Zoster Immunoglobulin in Patients with Varicella-Zoster Infection and Malignancy

References

• . Arala-Chaves, M. P., Ramos, M. T. F. & Porto, M. T.: Specific and nonspecific effects of transfer factor-dialyzable leukocyte extracts. In: Transfer factor, p. 87 (ed. M. S. Ascher, A. A. Gottlieb & C. H. Kirkpatrick). Academic Press, London 1975.
   Google Scholar
• . Armstrong, R. W., Gurwith, M. J., Waddell, D. & Merigan, T. C.: Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia. N Engl J Med 283: 1182, 1970.
   PubMed Web of Science ®Google Scholar
• . Bacon, G. E., Oliver, W. J. & Shapiro, B. A.: Factors contributing to severity of herpes zoster in children. J Pediatr 67: 768, 1965.
   Google Scholar
• . Bodey, G., McKelvey, E. & Karon, M.: Chickenpox in leukemic patients—factors in prognosis. Pediatrics 34: 562, 1964.
   PubMed Web of Science ®Google Scholar
• . Cantell, K., Hirvonen, S., Mogensen, K. E. & Pyhälä, L.: Human leukocyte interferon: production, purification, stability, and animal experiments. In: The production and use of interferon for the treatment and prevention of human virus infections; proceedings of a tissue culture association workshop. Monograph no. 3, p. 35 (ed. C. Waymouth). Tissue Culture Association, Rockville, Md. 1974.
   Google Scholar
• . Dahl, H. & Degré, M.: A microassay for mouse and human interferon. Acta Pathol Microbiol Scand (B) 80: 863, 1972.
   Google Scholar
• . Drew, W. L., Blume, M. R., Miner, R., Silverberg, I. & Rosenbaum, E. H.: Herpes zoster: transfer factor therapy. Ann Intern Med 79: 747, 1973.
   Google Scholar
• . Emödi, G. & Just, M.: Circulating interferon after transfer factor therapy. Lancet 2: 1382, 1973.
   PubMed Web of Science ®Google Scholar
• . Emödi, G., Rufli, T., Just, M. & Hernandez, R.: Human interferon therapy for herpes zoster in adults. Scand J Infect Dis 7: 1, 1975.
   PubMed Web of Science ®Google Scholar
• . Falksveden, L.: Swedish patent no. 348942
   Google Scholar
• . Feldman, S., Hughes, W. T. & Daniel, C. B.: Varicella in children with cancer: seventy-seven cases. Pediatrics 56: 388, 1975.
   PubMed Web of Science ®Google Scholar
• . Feldman, S., Hughes, W. T. & Kim, H. Y.: Herpes zoster in children with cancer. Am J Dis Child 126: 178, 1973.
   Google Scholar
• . Frøland, S. S., Natvig, J. B., Høyeraal, H. M. & Kåss, E.: The principle of immunopotentiation in treatment of rheumatoid arthritis: effect of transfer factor. Scand J Immunol 3: 223, 1974.
   PubMedGoogle Scholar
• . Goffinet, D. R., Glatstein, E. J. & Merigan, T. C.: Herpes zoster-varicella infections and lymphoma. Ann Intern Med 76: 235, 1972.
   PubMed Web of Science ®Google Scholar
• . Griscelli, C., Revillard, J. P., Betuel, H., Herzog, C. & Touraine, J. L.: Transfer factor therapy in immuno-deficiencies. Biomedicine 18: 220, 1973.
   PubMedGoogle Scholar
• . Haggerty, R. J. & Eley, R. C.: Varicella and cortisone. Pediatrics 18: 160, 1956.
   PubMed Web of Science ®Google Scholar
• . Han, T. & Sokal, J. E.: Lymphocyte response to phytohemagglutinin in Hodgkin's disease. Am J Med 48: 728, 1970.
   Google Scholar
• . Hersch, E. M. & Oppenheim, J. J.: Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med 273: 1006, 1965.
   Google Scholar
• . Hope-Simpson, R. E.: The nature of herpes zoster: a longterm study and a new hypothesis. Proc R Soc Med 58: 9, 1965.
   PubMedGoogle Scholar
• . Jackson, S. M., Garrett, J. V. & Craig, A. W.: Lymphocyte transformation changes during the clinical course of Hodgkin's disease. Cancer 28: 843, 1970.
   Google Scholar
• . Jordan, G. W., Fried, R. P. & Merigan, T. C.: Administration of human leukocyte interferon in herpes zoster. J Infect Dis 130: 56, 1974.
   PubMed Web of Science ®Google Scholar
• . Kernbaum, S.: Intravenous cytarabine in treatment of herpes zoster in haematological malignancy. Br Med J 1: 224, 1976.
   Google Scholar
• . Kouvalainen, K., Ruuskanen, O., Eskola, J. & Hopsu-Havu, V. K.: Herpes simplex-herpes zoster immunity. Scand J Infect Dis 5: 277, 1973.
   PubMed Web of Science ®Google Scholar
• . Lennette, E. H.: Complement fixation test. In: Diagnostic procedures for viral and rickettsial infections, 4th ed., p. 52 (ed. E. H. Lennette & N. J. Schmidt). American Public Health Association, New York 1969.
   Google Scholar
• . Merselis, J. G., Kaye, D. & Hook, E. W.: Disseminated herpes zoster. Arch Intern Med 113: 697, 1964.
   Google Scholar
• . Miller, L. H. & Brunell, P. A.: Zoster, reinfection or activation of latent virus? Am J Med 49: 480, 1970.
   PubMedGoogle Scholar
• . Mitchell, M. S., Wade, M. E., DeConti, R. C., Bertino, J. R. & Calabresi, P.: Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann Intern Med 70: 535, 1969.
   PubMed Web of Science ®Google Scholar
• . Movassaghi, N.: The prevention and treatment of varicella-zoster infection in patients at high risk. Clin Pediatr (Phila) 12: 299, 1973.
   Google Scholar
• . Pinkel, D.: Chickenpox and leukemia. J Pediatr 58: 729, 1961.
   PubMed Web of Science ®Google Scholar
• . Reymond, J.-F. & Grob, P. J.: Transfer factor preparations: Some physico-chemical and biological properties. Vox Sang 29: 338, 1975.
   Google Scholar
• . Rifkind, D.: The activation of varicella-zoster virus infections by immunosuppressive therapy. J Lab Clin Med 68: 463, 1966.
   PubMed Web of Science ®Google Scholar
• . Schimpff, S., Serpick, A., Stoler, B., Rumack, B., Mellin, H., Joseph, J. M. & Block, J.: Varicella-zoster infection in patients with cancer. Ann Intern Med 76: 241, 1972.
   PubMed Web of Science ®Google Scholar
• . Spirer, Z.: Prevention and treatment of varicella during steroid therapy. Lancet 1: 635, 1975.
   Google Scholar
• . Stevens, D. A., Ferrington, R. A., Jordan, G. W. & Merigan, T. C.: Cellular events in zoster vesicles: relation to clinical course and immune parameters. J Infect Dis 131: 509, 1975.
   PubMed Web of Science ®Google Scholar
• . Stevens, D. A., Jordan, G. W., Waddell, T. F. & Merigan, T. C.: Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial. N Engl J Med 289: 873, 1973.
   PubMed Web of Science ®Google Scholar
• . Stevens, D. A. & Merigan, T. C.: Interferon, antibody, and other host factors in herpes zoster. J Clin Invest 51: 1170, 1972.
   PubMed Web of Science ®Google Scholar
• . Strander, H., Cantell, K., Carlström, G. & Jakobsson, P. Å.: Clinical and laboratory investigations on man: systemic administration of potent interferon to man. J Natl Cancer Inst 51: 733, 1973.
   PubMed Web of Science ®Google Scholar
• . Taran, A.: A simple method for performing a Wasserman test on anticomplementary serum. J Lab Clin Med 31: 1037, 1946.
   PubMedGoogle Scholar
• . Uduman, S. A., Gershon, A. A. & Brunell, P. A.: Should patients with zoster receive zoster immune globulin? JAMA 234: 1049, 1975.
   Google Scholar
• . Vandvik, B., Frøland, S. S., Høyeraal, H. M., Stien, R. & Degré, M.: Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor. Scand J Immunol 2: 367, 1973.
   Google Scholar
• . Whitehead, R. H., Teasdale, C. & Hughes, L. E.: Correlation between tests of cell-mediated immunity. Lancet 2: 258, 1976.
   Google Scholar
• . Öberg, G. & Svedmyr, A.: Varicelliform eruptions in herpes zoster—some clinical and serological observations. Scand J Infect Dis 1: 47, 1969.
   PubMedGoogle Scholar